the aid library

LIST OPTIONS

Filter

12947

TB Toolbox
recommended

MEDBOX- The Aid libary (2022) CC

We have created a special Toolbox on Tuberculosis (TB), please click here to see all guidelines, manuals, reports & studies

Download (1455)

View PDF (5494)

Précautions standard pour contrôler les infections à l'hôpital

Organisation Mondiale de la Santé OMS (1998)

Download (2116)

View PDF (3181)

Best Practice Safety Protocols Clinical Procedures Safety

World Health Organization (2012)

Download (714)

View PDF (1057)

India: NATIONAL GUIDELINE FOR PARTNERSHIP

Government of India, Central Tuberculosis Division, Ministry of Health and Family Welfare (2014) C1

Download (1060)

View PDF (1402)

National Strategic Plan 2017-2025 for TB Elimination in India (Draft Version)

Government of India, Central Tuberculosis Division, Ministry of Health and Family Welfare (2017) C1

Download (927)

View PDF (1836)

FAST Job Aid General Medical Settings

United States Agency for International Development (USAID) (2013)

Download (2241)

View PDF (673)

Ethics - Practice Standard

College of Nurses of Ontario (2019) CC

This document describes the ethical values that are most important to the nursing profession in Ontario. It also provides scenarios of ethical situations in which there is a conflict of values. Nurses are encouraged to use these scenarios for reflection and discussion. No solutions are offered becau... more

Download (1147)

View PDF (1760)

Community-Based Care for Drug-Resistant Tuberculosis: A Guide for Implementers

United States Agency for International Development (USAID) (2011)

This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision. The target audience for this guide is TB Program Managers, governments, policy makers, nongovernmental organizatio... more

Download (455)

View PDF (627)

HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma - A Tale of Two Proteins: Tax and HBZ

Chou-Zen Giam; Semmes, Oliver John (2016) CC3

published in: Viruses 2016, 8, 161

Download (11675)

View PDF (2739)

Sterilization Manual for Health Centers

Silvia I. Acosta-Gnass and Valeska de Andrade Stempliuk PAHO; USAID (2009) C_WHO

Download (570)

View PDF (699)

India: Guidelines for Quality Assurance of smear microscopy for diagnosing tuberculosis

Government of India, Central Tuberculosis Division, Ministry of Health and Family Welfare (2005) C1

Download (412)

View PDF (553)

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

World Health Organization WHO (2023) C_WHO

This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...2021–2030 to attain the Sustainable Development Goals (SDGs) by 2030. The Lao People’s Democratic Republic experienced substantial economic growth in the 30 years prior to the coronavirus disease (COVID-19) pandemic, contributing to reduced poverty and significant progress toward the SDGs. However, the COVID-19 pandemic brought this development to a halt. It was anticipated that the COVID-19 recovery and the tremendous population growth in recent years would provide opportunities for a shift toward more sustainable and inclusive development in the years ahead. In 2023, however, the contrary was the case. Rural residents, including many ethnic minorities, continued to face marginalization because of limited access to education, health care and economic opportunities. Despite the challenges of COVID-19 and other disease outbreaks, the country has made significant improvements in health. Nonetheless, progress has been uneven and not everyone has benefited from these achievements. In the mountainous region, many people lack access to quality health care because of the unequal distribution of well-trained health-care workers. Preventable deaths due to poor-quality health care for children and newborns, infants and mothers remain a concern, as do communicable diseases such as sexually transmitted infections and tuberculosis. The increasing burden of noncommunicable diseases and the health impact of worsening climate change further heighten the need for strengthened and resilient health systems, which are at risk due to an underfunded health sector and weak economy. This CCS aims to address remaining and future challenges as well as health needs while creating an impact that is sustainable. It identifies three strategic priorities and nine deliverables (Table 1) to support the attainment of the national vision of Health for all by all, as articulated in the 9th Health Sector Development Plan 2021–2025. It contributes to the country’s goals to achieve universal health coverage, graduate from least developed country status by 2026 and attain SDGs by 2030. more

Download (415)

View PDF (516)

Limpieza y desinfección de las superficies del entorno inmediato en el marco de la COVID-19
recommended

Organización Mundial de la Salud OMS (2020) C_WHO

El propósito de este documento es proporcionar orientación sobre la limpieza y desinfección de las superficies ambientales en el contexto de COVID-19. Esta orientación está destinada a los profesionales de la salud, los profesionales de la salud pública y las autoridades sanitarias que están ... more

Download (3607)

View PDF (2105)

General Management, Administration and Operations QA/QI Checklist
recommended

Family Health International FHI (2007) C1

Download (357)

View PDF (493)

Уборка и дезинфекция помещений и поверхностей в контексте COVID-19

World Health Organization WHO (2020) C_WHO

Цель настоящего документа - дать указания по очистке и дезинфекции поверхностей окружающей среды в контексте КОВИД-19. Настоящее руководство предназначено для раб�... more

Download (459)

View PDF (380)

International health regulations (‎2005)‎: state party self-assessment annual reporting tool, 2nd ed

World Health Organization WHO (2022) C_WHO

Second edition. AVailable in English, French, Spanish, Russian, Chinese and Portuguese

Download (413)

View PDF (607)

Guidance on the prioritization of insecticide-treated nets in situations where resources are limited

World Health Organisation (WHO) (2023) C_WHO

In the context of limited resources, national malaria programmes may need to decide on how to prioritize all WHO-recommended interventions . This guidance document has been developed to support national malaria programmes in prioritization decisions, specifically on the deployment scope and product ... more

Download (1623)

View PDF (3330)

Integrated TB-HIV Outpatient Clinical Service (OPC) QA/QI Checklist

Family Health International FHI (2007) C1

This field guide is designed for use by FHI 360 staff and partner organizations responsible for ensuring quality clinical services, at both facility and non-facility levels. The guide provides general information on how to organize, implement and follow up on quality assurance/quality improvement cl... more

Download (1661)

View PDF (2233)

Clinical Facility and Services Assessment Field Guide
recommended

USAID; Family Health International FHI (2007) C1

Quality Assurance (QA) and Quality Improvement (QI). The guide provides general information on how to organize, implement and follow up on quality assurance/quality improvement clinical facility and service assessments. At the website you will find checklists intended to be used with the clinical fa... more

Download (503)

View PDF (718)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

TB Toolbox recommended

Limpieza y desinfección de las superficies del entorno inmediato en el marco de la COVID-19 recommended

General Management, Administration and Operations QA/QI Checklist recommended

Clinical Facility and Services Assessment Field Guide recommended

TB Toolbox
recommended

Limpieza y desinfección de las superficies del entorno inmediato en el marco de la COVID-19
recommended

General Management, Administration and Operations QA/QI Checklist
recommended

Clinical Facility and Services Assessment Field Guide
recommended